← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Bézafibrate currently has availability issues reported in 2 European registers: France, Italy.
Shortage ATC — · also listed as: bézafibrate · BEZAFIBRATO · data refreshed 8 September 2026
As of 8 September 2026, 2 of the 9 tracked registers list current availability issues for Bézafibrate, covering 2 affected product presentations. The longest-running open report was filed in Italy on 2025-04-17 and has now been open for about 17 months. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇫🇷 France | Limited availability Befizal L.P. 400 mg, comprimé enrobé à libération prolongée | — | — | Endocrinologie | register ↗ |
| 🇮🇹 Italy | Shortage BEZALIP | 2025-04-17 | — | Problemi produttivi Alternatives: AIFA: an alternative treatment is available (ask your doctor). | register ↗ |
Every individual register entry for Bézafibrate in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇹 IT | BEZALIP | Shortage | 2025-04-17 | — | Problemi produttivi |
| 🇫🇷 FR | Befizal L.P. 400 mg, comprimé enrobé à libération prolongée | Limited availability | — | — | Endocrinologie |
Yes. As of 8 September 2026, availability issues are reported in: France, Italy. Availability is national — a shortage in one country does not mean it is short everywhere.
1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Bézafibrate: ANSM (France), AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Bézafibrate — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bezafibrate/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Bézafibrate availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/bezafibrate/">Bézafibrate shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>